Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.

MLA

Coleman, M., et al. “Augmented Therapy of Extensive Hodgkin’s Disease: Radiation to Known Disease or Prolongation of Induction Chemotherapy Did Not Improve Survival--Results of a Cancer and Leukemia Group B Study.” International Journal of Radiation Oncology, Biology, Physics, vol. 41, no. 3, June 1998, pp. 639–45. EBSCOhost, https://doi.org/10.1016/s0360-3016(98)00071-6.

APA

Coleman, M., Rafla, S., Propert, K. J., Glicksman, A., Peterson, B., Nissen, N., Brunner, K., Holland, J. F., Anderson, J. R., Gottlieb, A., & Kaufman, T. (1998). Augmented therapy of extensive Hodgkin’s disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study. International Journal of Radiation Oncology, Biology, Physics, 41(3), 639–645. https://doi.org/10.1016/s0360-3016(98)00071-6

Chicago

Coleman, M, S Rafla, K J Propert, A Glicksman, B Peterson, N Nissen, K Brunner, et al. 1998. “Augmented Therapy of Extensive Hodgkin’s Disease: Radiation to Known Disease or Prolongation of Induction Chemotherapy Did Not Improve Survival--Results of a Cancer and Leukemia Group B Study.” International Journal of Radiation Oncology, Biology, Physics 41 (3): 639–45. doi:10.1016/s0360-3016(98)00071-6.